Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.

Mugavero MJ, May M, Ribaudo HJ, Gulick RM, Riddler SA, Haubrich R, Napravnik S, Abgrall S, Phillips A, Harris R, Gill MJ, de Wolf F, Hogg R, Günthard HF, Chêne G, D'Arminio Monforte A, Guest JL, Smith C, Murillas J, Berenguer J, Wyen C, Domingo P, Kitahata MM, Sterne JA, Saag MS; AIDS Clinical Trial Group DACS 241 Team; AIDS Clinical Trial Group Study 5095 Team; AIDS Clinical Trial Group Study 5142 team; Antiretroviral Cohort Collaboration.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):253-60. doi: 10.1097/QAI.0b013e318230372e.

2.

Measurement of antiretroviral drugs in the lungs of HIV-infected patients.

Twigg HL, Schnizlein-Bick CT, Weiden M, Valentine F, Wheat J, Day RB, Rominger H, Zheng L, Collman RG, Coombs RW, Bucy RP, Rezk NL, Kashuba AD.

HIV Ther. 2010 Mar 1;4(2):247-251.

3.

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.

Twigg Iii HL, Weiden M, Valentine F, Schnizlein-Bick CT, Bassett R, Zheng L, Wheat J, Day RB, Rominger H, Collman RG, Fox L, Brizz B, Dragavon J, Coombs RW, Bucy RP; AIDS Clinical Trials Group Protocol 723 Team.

J Infect Dis. 2008 Jan 1;197(1):109-16. doi: 10.1086/523766.

4.

Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

Janowicz DM, Tenner-Racz K, Racz P, Humphreys TL, Schnizlein-Bick C, Fortney KR, Zwickl B, Katz BP, Campbell JJ, Ho DD, Spinola SM.

J Infect Dis. 2007 May 15;195(10):1443-51. Epub 2007 Apr 5.

5.

Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects.

Wood KL, Knox KS, Wang Y, Day RB, Schnizlein-Bick C, Twigg HL 3rd.

Clin Immunol. 2005 Dec;117(3):294-301. Epub 2005 Nov 11.

PMID:
16290071
6.

Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.

D'Amico R, Yang Y, Mildvan D, Evans SR, Schnizlein-Bick CT, Hafner R, Webb N, Basar M, Zackin R, Jacobson MA.

J Clin Immunol. 2005 Mar;25(2):106-15.

PMID:
15821887
7.

Macrophages exposed to lymphotropic and monocytotropic HIV induce similar CTL responses despite differences in productive infection.

Knox KS, Day RB, Wood KL, Kohli LL, Hage CA, Foresman BH, Schnizlein-Bick CT, Twigg HL 3rd.

Cell Immunol. 2004 Jun;229(2):130-8.

PMID:
15474527
8.

Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var. capsulatum in experimentally infected mice.

Durkin MM, Connolly PA, Karimi K, Wheat E, Schnizlein-Bick C, Allen SD, Alves K, Tewari RP, Keath E.

J Clin Microbiol. 2004 Sep;42(9):4370-3.

9.

Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

Goldman M, Zackin R, Fichtenbaum CJ, Skiest DJ, Koletar SL, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA; AIDS Clinical Trials Group A5038 Study Group.

Clin Infect Dis. 2004 May 15;38(10):1485-9. Epub 2004 Apr 28.

10.

Effects of CD4 and CD8 T lymphocyte depletion on the course of histoplasmosis following pulmonary challenge.

Schnizlein-Bick C, Durkin M, Kohler S, Connolly P, LeMonte A, Garringer T, Goldberg J, Smedema M, Brizendine E, Wheat LJ.

Med Mycol. 2003 Jun;41(3):189-97.

PMID:
12964710
11.

Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.

Gordon SB, Miller DE, Day RB, Ferry T, Wilkes DS, Schnizlein-Bick CT, Zijlstra EE, Read RC, Molyneux ME, Twigg HL 3rd.

J Infect Dis. 2003 Sep 1;188(5):666-70. Epub 2003 Aug 20.

12.

Measurements of HIV viral loads from different levels of the respiratory tract.

Wood KL, Chaiyarit P, Day RB, Wang Y, Schnizlein-Bick CT, Gregory RL, Twigg HL 3rd.

Chest. 2003 Aug;124(2):536-42.

PMID:
12907539
13.

Effect of CD40 ligand on the course of murine histoplasmosis.

Wheat LJ, Durkin M, Schnizlein-Bick C, Bassey E, Kohler S, Connolly P, Goldberg J, Garringer T, Brizendine E, Thomas EK.

Med Mycol. 2002 Oct;40(5):501-5.

PMID:
12462530
14.

Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition.

Humphreys TL, Schnizlein-Bick CT, Katz BP, Baldridge LA, Hood AF, Hromas RA, Spinola SM.

J Immunol. 2002 Dec 1;169(11):6316-23.

15.

Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS.

Schnizlein-Bick CT, Mandy FF, O'Gorman MR, Paxton H, Nicholson JK, Hultin LE, Gelman RS, Wilkening CL, Livnat D.

Cytometry. 2002 Apr 15;50(2):46-52. No abstract available.

PMID:
12116345
16.

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.

AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):95-102.

PMID:
11839142
17.

Cellular immune response in HIV-infected patients with histoplasmosis.

Vail GM, Mocherla S, Wheat LJ, Goldberg J, Camp A, Brizendine E, Schnizlein-Bick C.

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):49-53.

PMID:
11782589
18.

Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides.

Batiuk TD, Schnizlein-Bick C, Plotkin Z, Dagher PC.

Am J Physiol Cell Physiol. 2001 Dec;281(6):C1776-84.

19.

Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis.

Durkin M, Kohler S, Schnizlein-Bick C, LeMonte A, Connolly P, Goldberg J, Garringer T, Wheat LJ.

J Infect Dis. 2001 Jun 15;183(12):1822-4. Epub 2001 May 16.

20.

beta(2)-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts.

Jaradat MI, Schnizlein-Bick CT, Singh GK, Moe SM.

Kidney Int. 2001 May;59(5):1951-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk